SubscribeThe following article is about Facility Monitoring Systems introduction of a Rapid Microbiology System.
Facility Monitoring Systems (FMS) is an established premier provider of critical monitoring systems to many industry sectors and is expanding to provide microbiological products and expertise to further enhance its ability to provide complete solutions for both new and existing clients. As part of this initiative, FMS is pleased to announce the addition of the Pallchek™ Rapid Microbiology system to its portfolio.
“The FDA encourages rapid microbiological methods as part of its PAT initiative for improved process control and product release. We are pleased to assist Pall Life Sciences in promoting the Pallchek Rapid Microbiology system in the UK” says FMS Commercial Director, Tim Russell.
"The FDA’s approval of rapid microbiology technology as a technique for product release sends a strong message of confidence in the test’s accuracy and sensitivity. It supports more routine and widespread use of bioluminescence rapid microbiology methods” says Loris Arbizzani, EU Rapid Microbiology Program Manager at Pall Life Sciences. “Twenty four hour rapid detection facilitates faster movement of products through the system while assuring safety.”
The Pallchek Rapid Microbiology System identifies the presence or absence of microbiological contamination in less than 24 hours by assessing the presence of a specific molecular marker of the test organisms. This means that pharmaceutical companies can take faster corrective action should contamination be identified. The Pallchek Rapid Microbiology System provides a simple, easy-to-use and cost effective tool to monitor microbiological contamination in final products, water for injection, raw materials and the manufacturing environment.
Pallchek is a trademark of Pall Corporation.